Biologic therapy in primary systemic vasculitis of the young

Eleftheriou D., Melo M., Marks S. D. , Tullus K., Sills J., Cleary G., ...Daha Fazla

RHEUMATOLOGY, cilt.48, ss.978-986, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 48 Konu: 8
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1093/rheumatology/kep148
  • Sayfa Sayıları: ss.978-986


Methods. This was a retrospective descriptive case series of children with PSV treated with biologic therapy between February 2002 and November 2007. Primary retrospective outcome assessment measures were: daily corticosteroid dose; Birmingham Vasculitis Activity Score (BVAS); and adverse events (including infection rate).